Delivery Order SPE2DB20D3103-SPE2DB25FP4N4
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,223.74 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 1, 2025, with a completion date of July 2, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The $38,059.36 firm fixed-price delivery order contract has a completion date of July 9, 2025 and was awarded on July 8, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition. Amerisourcebergen Drug...
- The federal contract award is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The $4,539.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 23, 2025, with a completion date of June 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support...
- The federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 17, 2025 with a ceiling value of $18,834.12. The contract is a firm fixed-price delivery order, without a set-aside designation, and has an ultimate completion date of July 18, 2025....
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The $14,230.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 21, 2025, with a completion date of May 22, 2025. The contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,928.02, is a delivery order for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication for the treatment of diabetes, to the Defense Logistics Agency (DLA). The $1,877.15 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 9, 2022 with an ultimate completion date of July 10, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at...
- The federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,420.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 29, 2025 with a completion date of May 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication, with a ceiling value of $84,327.60 and a completion date of June 6, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The federal contract award described is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,860.62 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 10, 2025, with a completion date of January 13, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical...